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Causes of albuminuria in patients with type 2 diabetes without In patients with type 2 diabetes, a clinical diagnosis
diabetic retinopathy. of diabetic nephropathy can be made if the following
Background. The causes of albuminuria in patients with type criteria are fulfilled: persistent albuminuria (.300 mg/2 diabetes are heterogeneous and are scantily investigated,
24 hours in at least 2 out of 3 consecutive, sterile, nonke-particularly if the patient has a lack of diabetic retinopathy.
totic, 24-hour urine samples), presence of diabetic reti-Therefore, we evaluated the structural background of albumin-
uria in a large consecutive group of Caucasian patients with nopathy (simplex or proliferative), and the absence of
type 2 diabetes without retinopathy. any clinical or laboratory evidence of other kidney or
Methods. Three hundred forty-seven consecutive patients renal tract disease [1]. Biopsy studies have shown thatwith type 2 diabetes with persistent albuminuria (.300 mg/
albuminuric patients with type 2 diabetes without reti-24 h) were recorded. Fundus photo (80%) and ophthalmoscopy
nopathy frequently suffer from nondiabetic kidney dis-were performed. Ninety-three (27%) had no retinopathy, and
a kidney biopsy was performed in 52 (56%) of these patients. ease [1–5], but the prevalence is not known. Further-
An insufficient tissue sample was obtained in one patient. The more, the potential role of demographic, clinical, and
biopsies were evaluated by three masked nephropathologists. laboratory data in separating the causes of albuminuriaResults. The biopsies revealed diabetic glomerulopathy in
has not been evaluated. Consequently, it is not possible69% of the patients (28 males and 7 females), while the re-
to establish the causes of albuminuria in patients withmaining 31% (95% CI, 18 to 44) had either nondiabetic glomer-
ulopathies such as glomerulonephritis (N 5 7, 6 males and 1 type 2 diabetes without retinopathy if a kidney biopsy
female, 13%) or normal glomerular structure (N 5 9, 7 males is not performed.
and 2 females, 18%). No significant differences in sex, age A correct diagnosis and a careful examination of the(56 6 8 vs. 53 6 10 years, mean SD), body mass index (30 6
glomerular and interstitial structure in patients with dia-4 vs. 31 6 8 kg/m2), known duration of diabetes (6 6 6 vs. 4 6 3
betes give important information on the course of glo-years), GFR (95 6 29 vs. 89 6 31 mL/min/1.73 m2), albuminuria
(1304 6 169 to 4731 vs. 1050 6 181 to 5176 mg/24 hours), merular filtration rate (GFR), risk of end-stage renal
blood pressure (150/87 6 16/9 vs. 145/89 6 16/9 mm Hg), disease (ESRD) development, and optimal treatment
prevalence of hypertension (89 vs. 100%), hemoglobin A1c (8.2 6 modalities for the different renal diseases in diabetic1.6% vs. 9.0 6 2.5%), and serum total cholesterol (7.1 6 2.4
patients [6–12].vs. 6.3 6 1.6 mmol/L) were found between patients with and
The aim of our study was to evaluate the cause ofwithout diabetic glomerulopathy.
Conclusions. Albuminuric patients with type 2 diabetes renal disease in a cohort of consecutive albuminuric pa-
without diabetic retinopathy have a prevalence of biopsies with tients with type 2 diabetes without retinopathy. Second,
normal glomerular structure or nondiabetic kidney diseases we evaluated the potential role of demographic, clinical,of approximately 30%. A separation between diabetic and
and laboratory data in separating diabetic from nondia-nondiabetic glomerular lesions was not possible based on de-
betic nephropathies, and finally, we evaluated the inter-mographic, clinical, or laboratory data. Consequently, such
patients may require further evaluation, including a kidney relationship between kidney structure and some of the
biopsy. previously mentioned data.
An interim report on a subset (N 5 20) of the present
(N 5 52) patients has previously been presented [1].Key words: nondiabetic glomerulopathies, hypertension, interstitial le-
sions, progressive renal disease, mesangial matrix, basement mem-
brane.
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Fig. 1. Selection procedure and findings in
patients with type 2 diabetes who were re-
ferred to kidney biopsy.
sterile, nonketotic, 24-hour urine samples), presence of two out of three consecutive, sterile, nonketotic, 24-hour
diabetic retinopathy (simplex or proliferative), and the urine samples) who had been or was attending the outpa-
absence of any clinical or laboratory evidence of other tient clinic at Steno Diabetes Center between 1978 and
kidney or renal tract disease [1]. 1998 were recorded.
Retinopathy was assessed following pupillary dilation Two hundred fifty-four patients had diabetic retinopa-
with direct ophthalmoscopy until 1989, when fundus pho- thy (simplex or proliferative), and 93 patients had no
tography became common. Retinopathy was graded as diabetic retinopathy. Fifty-eight of the patients without
nil, simplex, or proliferative; however, 80% percent of retinopathy were referred for a kidney biopsy, but six
the patients in this study were evaluated solely by fundus of these patients later decided not to participate. After
photography. 1992, our nephrologist decided not to perform kidney
Patients were considered to have type 2 diabetes if biopsy in patients with type 2 diabetes with albuminuria
they were treated with diet alone or in combination with of less than 1 g/24 hours. Consequently, 15 patients with-
oral hypoglycemic agents, or if they were treated with
out retinopathy and with albuminuria of ,1 g/24 hoursinsulin and had an onset of diabetes after the age of 40
were not evaluated. The remaining 20 patients were notyears and a body weight in excess of the ideal body
referred for a kidney biopsy because of the followingweight at the time of diagnoses [13]. All insulin-treated
reasons: (1) four patients died shortly after onset of albu-patients who were lean at the time of diagnosis had a
minuria, (2) seven patients were more than 65 years old,glucagon test performed, and type 2 diabetes was diag-
and (3) contraindications were present in nine patientsnosed if a stimulated C-peptide value was equal to or
(4 had a solitary kidney, 1 had a contracted kidney, andabove 0.60 pmol/mL [13].
4 patients were treated with anticoagulant because of
Patients cardiovascular disease) as shown in Figure 1. All patients
gave informed consent, and the study was performed inAll Caucasian (N 5 347) patients with type 2 diabetes
with persistent albuminuria (.300 mg/24 hours in at least accordance with the Helsinki Declaration.
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Laboratory techniques Biopsies
A renal biopsy was performed in 52 patients withoutAlbuminuria was measured by radioimmunoassay in
diabetic retinopathy but with persistent albuminuria.all urine samples until 1992 [14]. After 1992, an enzyme-
Twenty of these patients were enrolled in our initiallinked immunosorbent assay (ELISA) method was used
cross-sectional study [1]; insufficient material was ob-[15]. The correlation between the two methods was r 5
tained in one patient.0.99 [15]. The serum creatinine concentration was as-
The biopsies were evaluated by three masked nephro-sayed by a kinetic Jaffe method [16].
pathologists. To exclude/minimize bias with respect toGlomerular filtration rate was measured after a single
the presence of diabetic kidney lesions and to increaseintravenous injection of 3.7 MBq 51Cr-labeled ethylene-
possible variability in the morphometric analyses, wediaminetetraacetic acid (EDTA) by determination of the
mixed biopsies from patients with diabetes with 14 biop-radioactivity in venous blood samples taken from the
sies from subjects (6 women and 8 male) without diabe-other arm 180, 200, 220, and 240 minutes after the injec-
tes, with normal renal function, and normal structure bytion [17, 18]. The small underestimation (10%) of 51Cr-
light microscopy (LM), having a mean 6 SD age of 43 6EDTA clearance versus clearance of inulin was cor-
12.4 and a range of 20 to 61 years.rected for by multiplying EDTA clearance by 1.10 [17].
Furthermore, this gave us the opportunity to seeThe results were standardized for 1.73 m2 body surface
whether the upper normal range of Vv (mes/glom), mea-area. This method is precise (coefficient of variation 4%)
sured by our method, in our biopsies from patients with-and does not require frequent timed urine collections as
out diabetes with normal kidney structure differs fromdo the classic renal clearance procedures [17, 18].
other reports.All plasma clearance studies were carried out between
Seven biopsies were from patients suffering from mon-
9:00 a.m. and 1:30 p.m. Patients had their usual breakfast
osymptomatic albuminuria, and the remaining seven
and morning medication before the investigation, which
biopsies were from kidney donors. All morphometric
was carried out with the patient in the supine position. measurements were made by one of the authors (S.O.).
They drank 200 mL tap water per hour during the clear-
ance study. Light microscopy
Arterial blood pressure was measured with a clinical The tissue was fixed in 4% formaldehyde buffered to
sphygmomanometer after 10 minutes of rest. The mea- pH 7.0 (“Lillie’s fluid”), embedded in Paraplastt (Fisher
surements were taken with an appropriately sized cuff. Company, Fair Lawn, NJ, USA). Following the usual
Diastolic blood pressure was measured at the disappear- procedures of our laboratory, 4, 3, and 2 mm serial sec-
ance of the Korotkoff sounds (phase V). Arterial hyper- tions were cut and stained with hematoxylin eosin, peri-
tension was diagnosed according to the World Health Or- odic-acid Schiff, picric acid 1 Sirius red, Masson’s tri-
ganization criteria, systolic blood pressure $160 mm Hg, chrome, and silver methenamine 1 hematoxylin eosin.
and/or diastolic blood pressure $95 mm Hg, or if antihy- Only 2 mm sections were used for semiquantitative and
pertensive treatment was being prescribed. Mean arterial quantitative measurements.
blood pressure (MABP) was calculated as diastolic blood Diffuse diabetic glomerulopathy, hyaline arteriolo-
pressure plus one third of the pulse amplitude. sclerosis, tubular atrophy, and interstitial fibrosis were
Body mass index was calculated as body weight/height2 semiquantitatively estimated. The final reading (0, 11,
(kg/m2). 12, 13) of the three nephropathologists sitting together
Serum total cholesterol was measured using conven- was made by agreement at a video screen attached to
tional laboratory techniques. the microscope. The number of totally sclerotic glomer-
Hemoglobin A1c (HbA1c) was determined by using a uli was counted and expressed as a percentage of the
DIAMAT Analyzer (Bio-Rad, Hercules, CA, USA) un- total number.
til 1995 and thereafter by Variant Bio-Rad. The normal
Morphometryrange for HbA1c was 4.1 to 6.1% for both methods, with
a positive bias of 0.1 to 0.2% between the methods. The mesangial volume fraction [mesangium in a frac-
Neuropathy was measured by peripheral vibration tion of the total glomerular volume (Vv (mes/glom))]
perception threshold using a biothesiometer (Biomedical was measured at LM by point counting using a computer-
Instrument Co., Newbury, OH, USA). assisted stereological system (GRID; Interactivision, Den-
Microscopic examination of the urinary sediment was mark). Magnification on the video screen was 31650.
performed in a midstream specimen in all patients with The grid had 5 3 6 points. The number of points hitting
positive dipsticks for hemoglobin. Hematuria was de- the mesangium (matrix as well as cells) was expressed
fined as three or more erythrocytes per high-power field as the fraction of the points hitting the reference space,
which was the glomerulus defined as the circumscribedurinalysis of two or more sterile urine samples.
Christensen et al: Albuminuria in patients with type 2 diabetes1722
Fig. 2. Silver methenamine-stained section
of glomerulus with superimposed grid for esti-
mation of mesangial volume of the total glo-
merular volume [Vv (mes/glom)].
Fig. 3. Fibrotic scar circumscribed (white
line) for measurement of fractional area (sil-
ver methenamine staining).
minimal polygon. The measurements were made on brotic scar was circumscribed, and their areas were auto-
matically computed by the system. The sum of theseone silver methenamine-stained 2 m section from each
biopsy. One field from each of 6 to 10 glomeruli was areas was expressed as a percentage of the total cortical
area in the biopsy. In order not to miss any diffuse inter-measured (corresponding to 180 to 300 reference points),
excluding totally or partially sclerosed glomeruli (Fig. stitial fibrosis outside of these focal areas, we also mea-
sured the relative interstitial volume by point counting.2). Five biopsies contained less than six open glomeruli,
but had a minimum of 4. In these biopsies, two different The interstitial tissue including capillaries was expressed
as a fraction of the cortical labyrinth (cortex minus glo-fields in each glomerulus were measured. Using this LM
technique on plastic sections from 31 biopsies from pa- meruli and vessels larger than capillaries). Tubular base-
ment membranes were not included in the interstitialtients with diabetes and correlating the data with EM
morphometry on the same biopsies, a statistically sig- tissue.
nificant correlation was found (r 5 0.81, P , 0.0001;
Immunofluorescence microscopyR. Østerby, personal communication).
Interstitial fibrosis and tubular atrophy always oc- Kidney specimens were frozen using dry ice, embed-
ded in Tissue-Teck (Miles, Naperville, IL, USA) gelatin,curred in sharply defined focal areas (Fig. 3). Each fi-
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and 2 mm sections were cut at approximately 2248C on time of diagnosis of diabetes compared with 50% of the
patients without diabetic glomerulopathy (P 5 NS).a Leitz Histocryotome (Wetzlar, Germany). The direct
immunofluorescent staining technique was applied using There were significantly more males than females with
diabetic (P , 0.01) or nondiabetic glomerulopathiesFITC-conjugated rabbit or goat antisera specifically reac-
tive to human IgG, IgM, and IgA, as well as complement (P , 0.05).
Fifteen patients with albuminuria ,1 g/24 hours wereC1q, C3, and C4 [19].
not referred for a kidney biopsy. The male:female ratio
Electron microscopy (%) in the 15 patients were 87:13 compared with 80:20
in the 51 patients who were evaluated (P 5 NS). Further-Tissue had been processed for electron microscopy
(EM) in 24 out of the 51 kidney biopsies. The tissue more, no significant difference was found with respect
to the previously mentioned demographic, clinical, andwas fixed in 3% glutaraldehyde at pH 7.4, followed by
dehydration in increasing concentrations of ethanol. laboratory data between the two groups.
The mean 6 SD (range) number of glomeruli in pa-After fixation in 1% osmium tetroxide and embedding
in Epon, ultrathin sections were cut on an LKB I ultrami- tients without diabetes was 17 6 6.9 (9 to 31) and 14 6
8.8 (4 to 51) in the biopsies from patients with diabetes.crotone and examined on a Philips 100 electron micro-
scope. In all cases obtained before 1989, only the written All of the 51 biopsies from patients with diabetes
showed linear fluorescence for IgG in peripheral capil-reports were available (N 5 18), and blocks and ultrathin
sections had been discarded. lary walls [20].
Table 2 shows the histologic findings, including mo-
Statistical analysis phometric results, deposits of immunoglobulins, and
complement fractions and their localization in patientsValues are expressed as mean 6 SD or median
(range). Values for albuminuria were logarithmically with diabetic glomerulopathy. The number 6 SD (range)
of glomeruli in these biopsies was 16 6 8.9 (4 to 51).transformed before performing the statistical analysis
Two patients (patients 4 and 21) with diabetic glomer-because of their positively skewed distribution. All com-
ulopathy and well-preserved kidney function (GFR, 63parisons of normally distributed parameters were done
and 129 mL/min/1.73 m2) had persistent hematuria.with a Student’s t-test (unpaired design). Fisher’s exact
Apart from diabetic glomerulopathy, no other possibletest and chi-square test were used to evaluate propor-
cause was revealed by the urological/nephrological ex-tions or dichotomous variables. Linear regression analy-
aminations.sis was used to analyze for correlations. All calculations
Table 3 shows the histologic findings in patients withwere made using SPSS for Windows (SPSS Inc., Chicago,
normal glomerular structure. The number of glomeruliIL, USA). A P value of less than 0.05 was considered
in these biopsies was 12 6 7.9 (4 to 30).significant (two tailed).
Table 4 shows the histologic findings in the seven pa-
tients with structural changes indicating glomerulone-
RESULTS phritis. The number of glomeruli in these patients was
The kidney biopsy revealed diffuse (N 5 34) or nodu- 13 6 6.5 (4 to 22). Three had typical IgA nephropathy
lar (N 5 1) diabetic glomerulopathy in 69% (95% CI, consisting of mild mesangial proliferation with marked
56 to 82) of the patients. In the remaining 16 patients diffuse and global mesangial IgA deposits (patients 49,
(31%; 95% CI, 18 to 44), a normal glomerular structure 50, and 51). No tissue was available for EM from patients
was found in 9 (18%) and 7 (13%) biopsies that had 50 and 51; the EM in patient 49 did not show immuno-
different types of glomerulonephritis (discussed later in globulin deposits. In addition, patients 49 and 51 had
this article). severe diabetic glomerulopathy with scattered nodules,
The clinical features in relationship to the three pre- whereas patient 50 had mild diffuse diabetic glomerulo-
viously mentioned groups of patients are shown in Table pathy. Two other patients probably had IgA nephropa-
1. There were no significant differences in sex, age, thy, although not with typical abnormalities (45 and 48).
body mass index, antidiabetic treatment, antihyperten- These two patients had diffuse, global, and mild to mod-
sive treatment, HbA1c, serum total cholesterol, known erate mesangial IgA deposits, but no immunglobulin de-
duration of diabetes, albuminuria, GFR, serum creati- posits were detected on EM. In the biopsy from patient
nine, blood pressure, prevalence of hypertension, prev- 46, some corpuscles had adhesions between the glomeru-
alence of cardiovascular disease (CVD), and level of lar tuft and Bowman’s capsule in otherwise normal cor-
peripheral neuropathy between patients with diabetic puscles, which was interpreted as an indication of healed
glomerulopathy or glomerulonephritis, nor between pa- glomerulonephritis without activity. There were moder-
tients with diabetic glomerulopathy or normal glomeru- ate IgM deposits in the mesangial regions. Patient 47
lar structure. Thirty-four percent of the patients with had moderate mesangial proliferation without diabetic
sclerosis and C3 deposits in the glomeruli, but no immu-diabetic glomerulopathy already had albuminuria at the
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Table 1. Baseline data in 51 albuminuric patients with type 2 diabetes without diabetic retinopathy, with biopsy-proven diabetic
or nondiabetic glomerulopathy or with normal glomerular structure
Renal structure
Diabetic Normal glomerular
glomerulopathy Glomerulonephritis structure P value
Sex male/female 28/7 6/1 7/2 NS
Age years 56 (8.0) 51 (15) 54 (6) NS
Body mass index kg/m2 30 (4.4) 30 (5.2) 32 (9.8) NS
Antidiabetic treatment (diet/oral hypoglycemic/insulin) % 23/57/20 33/50/17 22/67/11 NS
Hemoglobin A1c % 8.2 (1.6) 9.1 (2.9) 8.9 (2.5) NS
Serum total cholesterol mmol/L 7.1 (2.4) 6.4 (1.6) 6.3 (1.7) NS
Known duration of diabetes years 4.0 (0–24) 6.0 (1–10) 4.0 (0–7) NS
Interval between known onset of proteinuria and first
GFR years 1.0 (0–9) 3.0 (0–6) 0 (0–5) NS
Albuminuria 1362 1431 1300 NS
mg/24 h (313–5499) (770–4143) (341–5460)
GFR mL/min/1.73 m2 95 (29) 83 (37) 94 (28) NS
Serum creatinine lmol/L 86 (51–148) 89 (52–186) 95 (53–104) NS
Systolic blood pressure mm Hg 150 (16.2) 148 (12) 144 (19) NS
Diastolic blood pressure mm Hg 87 (8.5) 91 (10) 88 (9) NS
Prevalence of hypertension % 89 100 100 NS
Prevalence of CVD % 32 17 29 NS
Peripheral vibration perception threshold mV 18 (8–50) 18 (8–50) 21 (10–50) NS
Data are mean (SD) or median (range). P values calculated between patients with diabetic glomerulopathy or normal glomerular structure, and between patients
with diabetic glomerulopathy or glomerulonephritis all were nonsignificant (NS).
noglobulins by immunofluorescent microscopy and no significant differences were found in any of the demo-
graphic, clinical, and laboratory variables.deposits on EM were found. We considered this case to
be possible mesangial proliferative glomerulonephritis. The interrelationships between a known duration of
diabetes, albuminuria, GFR, MABP, and renal structuralPatients with diabetic glomerulopathy had signifi-
cantly higher Vv (mes/glom) as compared with patients parameters are shown in Table 5. We found a significant
inverse correlation between the mesangial volume frac-without diabetic glomerulopathy 0.34 6 0.07 versus
0.27 6 0.08, respectively (P , 0.01). No significant differ- tion [Vv (mes/glom)] and GFR in patients with or with-
out diabetic glomerulopathy, and between percentage ofences were found in fraction of focal interstitial fibrosis
and tubular atrophy of the cortical area (0.11 6 0.14 vs. sclerotic glomeruli and GFR in patients with or without
0.10 6 0.16), diffuse interstitial volume (19.0 6 6.7 vs. glomerulopathy. The fraction of focal interstitial fibrosis
18.2 6 6.0), and percentage of sclerotic glomeruli (17 6 and tubular atrophy of the cortical area (FF) only showed
17.5 vs. 22 6 21.5) between patients with and without a significant inverse correlate with GFR in the patients
glomerulopathy, respectively. The individual values of without diabetic glomerulopathy. A significant correla-
Vv (mes/glom) in patients with diabetic glomerulopathy, tion in both groups was found between mesangial volume
normal structure, or glomerulonephritis are shown in fraction and albuminuria. In patients with nondiabetic
Figure 4. In our 14 patients without diabetes and without glomerulopathies, a strong, significant correlation was
glomerular lesions, the upper normal range of mesangial found between the percentage of sclerotic glomeruli and
volume fraction was 0.26 (Fig. 4). known duration of diabetes.
Twelve patients in all three groups had normal Vv No significant association was found between Vv (mes/
(mes/glom). If diabetic glomerulopathy is defined as Vv glom) and FF (r 5 0.12) in patients with diabetic glomer-
(mes/glom) exceeding the range of our patients without ulopathy, while a strong, significant association between
diabetes, four patients with diabetic glomerulopathy Vv (mes/glom) and FF (r 5 0.75, P , 0.01) was found
based on the subjective criteria belong to the normal in patients without diabetic glomerulopathy.
group, and conversely, two patients in that group must
be regarded as cases of diabetic glomerulopathy.
DISCUSSIONA comparison between our semiquantitative and mor-
This consecutive cohort study of albuminuric patientsphometric values demonstrated a highly significant cor-
with type 2 diabetes without diabetic retinopathy showedrelation (r 5 0.79, P , 0.0001). The individual values of
a high prevalence of normal glomerular structure andVv (mes/glom) correlated with semiquantitative grade
nondiabetic glomerulopathies of 31% (95% CI, 18 toof severity of the glomerulopathy are shown in Figure 5.
44). Normal glomerular structure was found in 18%, andIn our patients with diabetes with mesangial volume
fraction above or below 0.26 (upper normal limit), no different types of glomerulonephritis (predominantly
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Table 2. Renal pathology in 35 albuminuric patients with type 2 diabetes without diabetic retinopathy and diabetic glomerulosclerosis
Light and electron microscopy
Immune depositsaGrading of Nondiabetic
Patient Diabetic severity Vv S/G Arteriolar glomerular Immuno- Complement
no. glomerulosclerosis of DGS mes/glom FF % hyalinosis lesions globulins fractions
01 Diffuse 1 0.24 0.02 10 3 Absent 0 0
02 Diffuse 1 0.31 0.01 0 1 Absent 0 0
03 Diffuse 1 0.38 0.25 25 2 Absent 0 0
04 Diffuse 3 0.39 0.14 15 3 Absent IgA, IgM 0
05 Diffuse 2 0.42 0.04 29 2 Absent 0 C3
06 Diffuse 1 0.27 0.03 11 1 Absent 0 0
07 Nodular 3 0.56 0.16 13 1 Absent No tissue
08 Diffuse 1 0.25 0.58 20 1 Absent IgM C1c
09 Diffuse 1 0.25 0.11 6 1 Absent IgA, IgM 0
10 Diffuse 2 0.41 0.02 9 3 Absent 0 0
11 Diffuse 1 0.28 0.10 0 2 Absent 0 0
12 Diffuse 2 0.37 0.04 8 2 Absent IgM 0
13 Diffuse 2 0.38 0.04 25 2 Absent IgA, IgM 0
14 Diffuse 3 0.38 0.03 40 3 Absent No tissue
15 Diffuse 1 0.31 0.55 80 3 Absent No tissue
16 Diffuse 1 0.30 0.01 0 1 Absent 0 0
17 Diffuse 1 0.27 0.09 0 2 Absent IgA 0
18 Diffuse 1 0.32 0.09 0 3 Absent ND ND
19 Diffuse 1 0.30 0.05 0 3 Absent IgA 0
20 Diffuse 1 0.30 0.06 44 3 Absent 0 0
21 Diffuse 3 0.36 0.09 19 3 Absent IgA C3, C4
22 Diffuse 1 0.30 0.04 4 3 Absent No tissue
23 Diffuse 1 0.34 0.11 13 2 Absent ND ND
24 Diffuse 1 0.37 0.01 5 3 Absent 0 C3
25 Diffuse 1 0.29 0.06 6 1 Absent 0 0
26 Diffuse 2 0.36 0.26 42 3 Absent IgA, IgM 0
27 Diffuse 1 0.27 0 0 1 Absent 0 0
28 Diffuse 1 0.38 0.14 23 2 Absent IgA 0
29 Diffuse 1 0.30 0.07 50 2 Absent No tissue
30 Diffuse 2 0.43 0.08 30 2 Absent 0 0
31 Diffuse 2 0.36 0.09 17 1 Absent IgM 0
32 Diffuse 1 0.24 0.08 20 1 Absent ND ND
33 Diffuse 1 0.30 0.01 9 2 Absent 0 0
34 Diffuse 2 0.53 0.38 18 3 Absent IgA 0
35 Diffuse 1 0.33 0.08 13 1 Absent IgA, IgM 0
Abbreviations are: DGS, diabetic glomerulosclerosis; Vv (mes/glom), mesangial volume of the total glomerular volume; FF, fractional area of focal interstitial
fibrosis and tubular atrophy of cortical area; S/G, percentage of sclerosed glomeruli of the total number of glomeruli in each biopsy; Slight 5 1, medium 5 2, severe
5 3; ND, no data.
a All deposits of immunoglobulins and complement fractions were mild or questionable, frequently only present in a few glomeruli and without characteristic
pattern
Table 3. Renal pathology in 9 albuminuric patients with type 2 diabetes without diabetic retinopathy, with normal glomerular structure
Light and electron microscopy
Immune depositsaNondiabetic
Patient Diabetic Vv S/G Arteriolar glomerular Immuno- Complement
no. glomerulosclerosis mes/glom FF % hyalinosis lesions globulins fractions
36 Absent TI 0.08 33 1 Absent 0 0
37 Absent 0.23 0.08 17 1 Absent 0 0
38 Absent 0.27 0.04 0 1 Absent 0 0
39 Absent 0.23 0.01 0 0 Absent 0 0
40 Absent 0.26 0 0 2 Absent 0 0
41 Absent 0.30 0.08 8 1 Absent 0 0
42 Absent 0.19 0.06 33 2 Absent IgA 0
43 Absent TI 0.07 50 3 Absent IgM C1, C3, C4
44 Absent 0.17 0.20 33 2 Absent ND ND
Abbreviations are: Vv (mes/glom), mesangial volume of the total glomerular volume; FF, fractional area of focal interstitial fibrosis and tubular atrophy of cortical
area; S/G, percentage of sclerosed glomeruli of the total number of glomeruli in each biopsy; Slight 5 1, medium 5 2, severe 5 3; ND, no data; TI, technical not
possible.
a All deposits of immunoglobulins and complement fractions were mild or questionable, frequently only present in a few glomeruli and without characteristic
pattern
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Table 4. Renal pathology in 7 albuminuric patients with type 2 diabetes without diabetic retinopathy and with glomerulonephritis
Light and electron microscopy Immunofluorescence microscopy
Immune deposits
LocalizationDiabetic Grading of NondiabeticPatient glomerulo- severity Vv S/G Arteriolar glomerular Immuno- Complement
no. sclerosis of DGS mes/glom FF % hyalinosis lesions globulins fractions Mesangium Capillary
45 Absent 0.22 0.01 14 2 Mild mesangial IgA, IgM C3 1 1
prolif. GN
(IgA?)
46 Absent 0.24 0.05 20 3 GN sequelae IgM 0 1 1
47 Absent TI 0.01 8 3 Mild mesangial 0 C3 1 1
prolif. GN
48 Diffuse 1 0.31 0.02 TI 0 Probable IgA IgA, IgM 0 1 1
nephropathy
49 Nodular 2 0.37 0.24 56 3 IgA nephrop- IgA, IgM 0 1 1
athy
50 Diffuse 1 0.23 0 0 1 IgA nephrop- IgA, IgM C3, C4 1 1
athy
51 Nodular 3 0.47 0.66 64 3 IgA nephrop- IgA, IgM C3 1 1
athy
Abbreviations are: DGS, diabetic glomerulosclerosis; Vv (mes/glom), mesangial volume of the total glomerular volume; FF, fractional area of focal interstitial
fibrosis and tubular atrophy of cortical area; S/G, percentage of sclerosed glomeruli of the total number of glomeruli in each biopsy; Slight 5 1, medium 5 2,
severe 5 3; ND, no data; TI, technical not possible.
Fig. 4. Mesangial volume expressed as a frac-
tion of total glomerular volume in patients
with type 2 diabetes with diabetic glomerulo-
pathy, glomerulonephritis, and normal glo-
merular structure and in control patients. Fig-
ures indicate the median (range) in the
respective groups.
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Fig. 5. Mesangial volume expressed as a frac-
tion of total glomerular volume in albuminuric
patients with type 2 diabetes. Patients were
divided in accordance to a semiquantitative
estimation of the severity of the glomerulo-
pathy (nil, 0; slight, 11; medium, 12; and se-
vere, 13).
IgA nephritis) were found in 13%. Regardless of whether information on the kidney disease by solely analyzing
the clinical data.the glomerular changes in the aforementioned group
are responses to the diabetic state or represent other Type 2 diabetes is a male-predominated disease. The
male:female ratio (%) in all patients with type 2 diabetesdiseases, they are, nonetheless, quite atypical of what
has come to be described as classic diabetic glomerulopa- attending our outpatient clinic was 56:44. The percentage
in type 2 patients with clinical diabetic nephropathythy, and we have preferred to keep our diabetic patients
apart from this group. Patients with or without diabetic (presence of diabetic retinopathy and albuminuria .300
mg/24 h) was 68:32, whereas the male:female ratio ofglomerulopathy were not significantly different with re-
gards to demographic, clinical, and laboratory data at 80:20 was demonstrated in the present albuminuric pa-
tients without retinopathy. In our previous cross-sec-baseline, and it must be emphasized that the sole indica-
tion for kidney biopsy in our study was the presence of tional study [1], the male:female ratio in patients without
retinopathy was 89:11. The male predominance in thealbuminuria and the lack of diabetic retinopathy. In
other words, we had no clinical suspicion of a nondiabetic albuminuric patients in our studies was more marked
compared with previous investigations [21–23]; however,nephropathy. Consequently, it was not possible to pre-
dict the causes of albuminuria or to obtain any prognostic these studies included patients with retinopathy. No
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Table 5. Interrelationships between clinical and laboratory findings and renal lesions in 51 albuminuric patients
with type 2 diabetes without diabetic retinopathy
Known duration Albuminuria Glomerular Mean arterial
of diabetes (log10) filtration rate blood pressure
years mg/24 h ml/min/1.73 m2 mm Hg
r P r P r P r P
Patients with diabetic
glomerulopathy (N 5 35)
Vv mes/glom 10.20 NS 10.32 0.06 20.43 ,0.01 10.15 NS
FF 20.24 NS 10.21 NS 20.16 NS 10.06 NS
S/G % 10.19 NS 10.33 0.06 20.39 ,0.05 20.04 NS
Patients with nondiabetic
glomerulopathy (N 5 16)
Vv mes/glom 10.44 NS 10.68 ,0.05 20.69 ,0.01 10.12 NS
FF 10.34 NS 10.42 NS 20.54 ,0.05 10.41 NS
S/G % 10.67 ,0.01 10.20 NS 20.65 ,0.01 10.49 0.06
Abbreviations are: Vv (mes/glom), mesangial volume of the total glomerular volume; FF, fractional interstitial area of focal fibrosis and tubular atrophy of cortical
area; S/G, percentage of sclerosed glomeruli of the total number of glomeruli in each biopsy.
other data are available to establish the male:female albuminuria ranging from 70 to 4210 mg/24 hours, and
reported nonspecific vascular and glomerular change inratio in patients with type 2 diabetes with albuminuria
and without retinopathy. Selection bias in the present 15% of the patients [5]. Among 36 hypertensive, albu-
minuric patients with type 2 diabetes with serum creati-study may be possible, but can only partly explain the
male predominance, since the male:female ratio, the de- nine between 133 and 265 mmol/L, Schwartz et al found
6% of the patients to have nondiabetic glomerulopathymographic, clinical, and laboratory data in the 51 patients
included in the present study did not differ significantly [2]. The low prevalence of 6% [2] may be attributed to
the inclusion criteria. All patients with diabetic retinopa-from the 15 patients with ,1 g albuminuria/24 hours
not included. Furthermore, the number of patients with thy had diabetic glomerulopathy, and the two patients
with nondiabetic glomerulopathy lacked diabetic reti-albuminuria at the time of diagnosis of diabetes was
nearly the same in the two groups. All of the patients had nopathy. A close relationship between the degree of
diabetic retinopathy and diabetic glomerulopathy haswell-preserved kidney function, and the interval between
known onset of albuminuria and finally baseline evalua- been demonstrated in albuminuric type 2 diabetic pa-
tients [11]. In other biopsy series, the prevalence of non-tion in the two groups was not significantly different.
Recently, four studies applying an unbiased indication diabetic glomerulopathies varies from 9 to 66% [24];
however, in all of these studies except one [1], biopsiesfor kidney biopsy have been reported in microalbumi-
nuric and macroalbuminuric patients with type 2 diabetes were taken on clinical indications and were not per-
formed on the basis of research protocols.[2–5]. All of these studies included patients with and
without diabetic retinopathy. Fioretto et al, by using The prevalence of patients without diabetic glomeru-
lopathy in the present study is, as expected, higher thanLM, described a heterogeneity in renal structure in 34
microalbuminuric patients with type 2 diabetes: 29% had in most of the previously mentioned studies in which
patients with clinical diabetic nephropathy were in-normal or near normal renal structure, and 50% of these
patients had no retinopathy [3]. The same group of inves- cluded. Our finding of normal glomerular in 18% may,
however, be a conservative estimate since the criteriatigators extended these data in a cohort study of 53
patients with type 2 diabetes with microalbuminuria [4]. for performing kidney biopsy were changed in the study
period from albuminuria persistently above 300 mg toForty-one percent of these patients had normal or near
normal biopsies, and in 59% of these patients, no reti- albuminuria persistently above 1 g.
The histologic classification of the renal lesions wasnopathy was seen [4]. In biopsies revealing mainly in-
terstitial changes (33%), only 31% had retinopathy, performed according to the World Health Organization
standard [25]. All biopsies were reviewed by three expe-whereas all patients with obvious diabetic glomerulo-
pathy (26%) had retinopathy [4]. In contrast to these rienced nephropathologists in a blinded fashion. Further-
more, we mixed the 51 biopsies with 14 biopsies fromstudies [3, 4], we found a lower prevalence of normal
glomerular structure, but this must be expected since nondiabetic patients with normal renal structure in order
to minimize and/or exclude bias.we only included patients with macroalbuminuria (.300
mg/24 hours). By routine evaluation of renal biopsies, diabetic glom-
erulopathy was diagnosed and semiquantitatively gradedCordonnier et al investigated 26 type 2 patients with
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by subjective evaluation, and this was also the method tionate tubulointerstitial changes, which were frequent
in these studies but rare in our biopsies, have the appear-by which we made the diagnosis at the original reading
of the biopsies; however, it must be regarded as inferior ance of small scars and are probably sequelae to arter-
iolosclerosis and arteriosclerosis. These abnormalitiesto quantitative morphometry. Since only a part of our
biopsies included tissue for EM, we used a morphometric occur in biopsies with as well as without diabetic glom-
erulopathy, and it is possible that such lesions may bepoint count technique on LM specimens, a method that
works well on high-quality 2 m paraffin sections stained partly responsible for albuminuria induced in the surviv-
ing and probably hyperfunctioning glomeruli in kidneysby silver methenamine. Furthermore, the conventional
method of measuring the fractional volume of cortical with widespread scarring. However, our patients with as
well as those without glomerulopathy included cases withfibrosis in biopsies with rather few and small focal fibrosis
areas is very insensitive since the fibrosis will largely marked focal fibrosis. In the group without mesangial
expansion, patients 8, 42, and 44 may belong to the cate-“disappear” in the many measuring fields outside the
areas with fibrosis. We therefore also selected another gory with atypical pattern. The comparatively weak cor-
relation (r 5 0.28; P 5 0.03) between hyaline arteriolarobjective method to evaluate fibrosis.
A comparison between the semiquantitative grading change and focal fibrosis in our biopsies does not speak
decisively against this hypothesis because of the highand morphometric values of mesangial expansion dem-
onstrated a highly significant correlation; however, prob- risk of sampling error involved in the estimation of these
focal lesions.lems with the subjective evaluation are obvious. It may
be of less practical relevance that it appears to be impos- Undetected focal segmental glomerulosclerosis (FSG)
could be another explanation of albuminuria. However,sible semiquantitatively to distinguish between diffuse
diabetic glomerulopathy grades 12 and 13. More impor- our biopsies with normal glomeruli were from a general
point of view representative, and their number of glo-tant is the overlap between the morphometric values
corresponding to grade 0 and 11, indicating that the meruli had a range of 4 to 30. The possibility that FSG
is occasionally responsible for albuminuria in a diabeticcutoff point between subjectively determined normal
biopsies and mild diabetic glomerulopathy is somewhat patient with apparently normal glomeruli cannot be to-
tally excluded, since a biopsy is less sensitive to the diag-arbitrary. In fact, four patients subjectively estimated
to have diabetic glomerulopathy had Vv (mes/glom) nosis of FSG, but we regard the probability as small.
The low incidence of Kimmelstiel–Wilson nodulesslightly below 0.26, which was within the normal range
of our controls (mean value of controls, 0.18 6 0.04, found in our biopsies was expected, since all our patients
with diabetic nephropathy had well-preserved kidneyfitting well with normal values reported by ultrastruc-
tural morphometry) [26], and two patients with normal function and early-stage diabetic nephropathy.
Albuminuria in patients without diabetes can be asso-glomerular structure had a Vv (mes/glom) value above
the upper normal range. ciated with normal glomeruli, a not very well-defined con-
dition often called “minor change nephropathy,” whichThe cause of albuminuria in patients without diabetic
glomerulopathy is unclear. It might conceivably be due includes the more well-defined entity “minor change ne-
phrotic syndrome.” Both conditions are characterizedto early, and thus very slight, diabetic changes that are
undetectable by LM, but this seems less probable since morphologically by glomeruli with normal or only minor
lesions by LM and with foot process fusion as the onlyearly ultrastructural changes usually (at least in patients
with type 1 diabetes) are present in normoalbuminuric ultrastructural change. Seven of our 13 patients without
glomerulopathy [LM normal glomerular structure and/oror microalbuminuric patients [27–29], and not in patients
with overt nephropathy such as our study group. Vv (mes/glom) ,26] were investigated with EM, and
normal morphology was found in three cases. ObviousNo significant difference in focal or diffuse fibrosis, the
percentage of sclerotic glomeruli, or arteriolar hyaline variable degrees of foot process fusion were noted in
the remaining four. Fusion of the foot processes is, how-change was demonstrated between biopsies revealing
normal morphology and biopsies with diffuse glomerulo- ever, not specific and can be seen in other renal diseases
associated with albuminuria [31].pathy. Immunofluorescence microscopy was negative in
most biopsies with normal glomerular structure. Only Finally, albuminuria in diabetics without glomerulopa-
thy could be caused by alterations of the moleculartwo had weak or questionable immunoglobulin deposits
and only in some of the glomeruli. Atypical patterns of structure of the glomerular basement membrane and
increased glomerular permeability to macromoleculesrenal injury in patients with type 2 diabetes have been
reported: no or mild diabetic glomerulopathy, but dis- (size/charge defects). Alternatively, the defect in the cap-
illary wall barrier, as suggested by Fioretto et al, couldproportionate severe renal tubulointerstitial changes, tu-
bular atrophy and interstitial fibrosis, advanced arteriolar be due to endothelial dysfunction [32]. Actually, such
hypothetical diabetic capillary wall alterations could con-sclerosis, global glomerular sclerosis, and atheroscler-
osis of larger arteries [3, 4, 30]. The severe and dispropor- stitute the primary cause of glomerulopathy, with mesan-
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gial matrix and basement membrane augmentation as kidney diseases in albuminuric patients with type 2 dia-
betes without retinopathy. A separation between dia-an epiphenomenon. Conversely, albuminuria may partic-
ipate in the initiation and progression of the tubulointer- betic and nondiabetic glomerular lesions was not possible
based on demographic, clinical, or laboratory data. Con-stitial lesions, as suggested by Remuzzi and Bertani [33].
The most characteristic and clinically important glo- sequently, such patients may require further evaluation,
including a kidney biopsy.merular lesion in diabetes mellitus is mesangial expan-
sion, and a precise quantitation of renal tissue injury
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combined with clinical and laboratory data can be used Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
as a reliable predictor of the risk of ESRD [11, 34].
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